I agree with you. The main problem with Mayne's generic business was that a significant proportion was landed with the TEVA acquisition. Generics of their own products like doxycycline have protected their market share, and there are probably others doing well too.
MYX Price at posting:
29.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)